1Kallioniemi A. Molecular signatures of breast cancer-predicting the future[J]. Previous, 2002, 347(25): 2067-2068
2Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights:international consensus pannel on the treatment of primary breast cancer[J].J Clin Oncol, 2001, 19(18): 3817-3827
3Stefanie SJ, MichaelJF, Anne-Lise BD, et al. Expression array technology in the diagnosis and treatment of breast cancer [J].Molecular Interventions, 2002, 2(2): 101-109
4Nishizuka I, Ishikawa T, Hamaguchi Y, et al. Analysis of gene expression involved in brain metastasis from breast cancer using cDNA microarray[]]. Breast Cancer, 2002,9(1): 26-32
5Deborah AZ, Marty FB, Yan Gong, et al. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells[J]. Cancer Res, 2001, 61(13): 5168-5178
6Evtimova V, Schwirzke M, Tarbe N, et al. Identification of breast cancer metastasis-associated genes by chip technology [J]. Anticancer Res, 2001, 21(6A): 3799-3809
8Dennis CS, Sarena T, Greg R, et al. In vivo gene expression profile analysis of human breast cancer progression[J]. Cancer Res,1999, 59(22): 5656-5661
9Leone A, Flatow U, Van Houtte K, et al. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity[J]. Oncogene, 1993, 8(9): 2325～2333
10Malanie TH, Susan EC, Micheal M, et al. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition [J]. Cancer Res,2001, 61(5): 2320-2327
4[1]O'Driscoll L,Clynes M.Biomarkers and multiple drug resistance in breast cancer[J].Curr Cancer Drug Targets,2006,6(5):365-384.
5[2]Crown J.Chemotherapy dose and schedule in adjuvant treatment of breast cancer:phoenix,turkey,or dodo?[J].Lancet,2003,352(9385):577-678.
6[3]Ikeda T,Jinno H,Kitajima M.The evolution of primary chemotherapy in breast cancer treatment[J].Breast Cancer,2004,11(2):148-155.
7[4]Jeffrey S S,Fero M J,Borresen-Dale A L,et al.Expression array technology in the diagnosis and treatment of breast cancer[J].Mol Interv,2002,2:101-109.
8[6]Bertucci F,Nasser V,Granjeaud S,et al.Gene expression profiles of poor-prognosis primary breast cancer correlate with survival[J].Hum Mol Genet,2002,11(8):853-872.
9[7]Lee C H,Macgregor P F.Using microarrays to predict resistance to chemotherapy in cancer patients[J].Pharmacogenomics,2004,5 (5):611-625.
10[8]Perquin M,Oster T,Maul A,et al.The glutathione-relatedetox-ification pathway in the human breast:a highly coordinatedsystem disrupted in the tumour tissues[J].Cancer Lett,2000,158(1):7-16.
